Polystyrene sulfonic acid clinical trials
Also written Sodium polystyrene sulfonate and Kayexalate.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 1992
How each study uses polystyrene sulfonic acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 5 Jun 1958 · KAYEXALATE · NDA 011287 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 1992 (1)
| Year | Studies |
|---|---|
| 1992 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 4
Alexandria University (1) · Maisonneuve-Rosemont Hospital (1) · National Center for Research Resources (NCRR) (1) · University of California, Irvine (1) · ZS Pharma, Inc. (1)
Often tested with
Tested in the same studies.
Sodium zirconium cyclosilicate (2) · Enalapril (1) · Polyethylene glycol 3350 (1) · Patiromer (1)
Related medicines
As reviewed, each with the page that says it.
- One of Chelating Agents source
Studies
Open first, then newest update. How each study uses polystyrene sulfonic acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Comparison of Potassium Binders in the ERTerminatedPhase 4University of California, IrvineNCT04585542Written as Sodium Polystyrene Sulfonate Oral Suspension [SPS]How we know
- SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis PatientsCompletedNot applicableAlexandria UniversityNCT06029179Written as sodium polystyrene sulfonateHow we know
- Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis PatientsCompletedPhase 4Maisonneuve-Rosemont HospitalNCT02065076Written as Sodium polystyrene sulfonateHow we know
- Safety and Efficacy of Sodium Polystyrene Sulfonate in HyperkalemiaTerminatedPhase 4ZS Pharma, Inc.NCT01866709Written as Sodium polystyrene sulfonateHow we know
- Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type ICompletedPhase 2National Center for Research Resources (NCRR)NCT00004328Written as polystyrene sulfonateHow we know
Codes
What other systems call polystyrene sulfonic acid · ClinicalTrials.gg INT002271
- MeSH (NLM) C003321polystyrene sulfonic acidConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 70KO0R01RYPOLYSTYRENE SULFONIC ACIDOne source NLM
- RxNorm 1546436One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C003321 | polystyrene sulfonic acid | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 70KO0R01RY | POLYSTYRENE SULFONIC ACID | One source NLM |
| RxNorm | 1546436 | — | One source FDA |
Also registered as calcium polystyrene sulfonate (UNII HUI2S00793 · RxNorm 47630) and sodium polystyrene sulfonate (UNII 1699G8679Z · RxNorm 56512).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.